LONDON BROKER RATINGS: Berenberg says 'buy' Elixirr International

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

----------

FTSE 100

----------

JPMorgan raises Antofagasta price target to 3,200 (3,100) pence - 'neutral'

----------

Citigroup raises AstraZeneca price target to 18,000 (17,000) pence - 'buy'

----------

Barclays raises Airtel Africa price target to 360 (350) pence - 'overweight'

----------

JPMorgan raises London Stock Exchange price target to 13,700 (13,600) pence - 'overweight'

----------

Goldman Sachs cuts HSBC price target to 1,650 (1,675) pence - 'buy'

----------

FTSE 250

----------

Barclays raises Jupiter Fund price target to 155 (145) pence - 'underweight'

----------

Barclays cuts Ashmore Group price target to 175 (180) pence - 'underweight'

----------

SMALL CAP AND AIM

----------

Berenberg starts Elixirr International with 'buy' - price target 1,060 pence

----------

Berenberg raises Devolver Digital price target to 28 (25) pence - 'buy'

----------

Berenberg cuts Impax Asset Management price target to 170 (300) pence - 'buy'

----------

Jefferies raises Glenveagh Properties price target to 2.41 (2.36) EUR - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Glenveagh

Impax Asset Management

Devolver Dig. S

Elixirr International

Ashmore Group

Jupiter Fund Management

HSBC Holdings

London Stock Exchange

Airtel Africa

Astrazeneca

Antofagasta